Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 336 validity ...
Reply New Message
Prev Message Back To Forum Threaded View Next Message
"If TPL was not absolutely positive about the validity of the 148 and 336, then I would say TPL settled for their low end (say 30 million per J3) because they wanted to get absolute validity from the USPTO before going into an all or nothing type scenario like a trial."
Hm, 30million would be strange given the fact that Fujitsu settled for $ 30mio TWO years ago without all the litigation hazzle.
Thus my guess would be, that the numbers for the "low end case" (= worst case) are more to $ 50mio.
But as SGE says: IKN!
2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply